Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald W Light

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
The American Journal of Bioethics : AJOB|March 24, 2004
Will lower drug prices jeopardize drug research? A policy fact sheetDonald W Light, Joel Lexchin
BMJ (Clinical Research Ed.)|September 25, 2015
The FDA's new clothesDonald W Light, Joel Lexchin
The New England Journal of Medicine|July 19, 2013
Regulation of drugs for early Alzheimer's diseaseDonald W Light, Jonathan Darrow
Social Science & Medicine (1982)|March 25, 2011
Reflections on commissioning and the English coalition government NHS reformsDonald W Light, Martin Connor
BMJ (Clinical Research Ed.)|April 25, 2015
Why do cancer drugs get such an easy ride?Donald W Light, Joel Lexchin
The Hastings Center Report|August 11, 2006
A conservative case for universal access to health carePaul Menzel, Donald W Light
BMJ (Clinical Research Ed.)|March 18, 2018
Trump blames free riding foreign states for high US drug pricesDonald W Light, Arthur L Caplan
Social Science & Medicine (1982)|September 26, 2020
Pharmaceuticals as a market for "lemons": Theory and practiceDonald W Light, Joel R Lexchin
BMJ (Clinical Research Ed.)|August 9, 2012
Pharmaceutical research and development: what do we get for all that money?Donald W Light, Joel R Lexchin
Journal of Health Economics|August 10, 2005
Extraordinary claims require extraordinary evidenceDonald W Light, Rebecca N Warburton
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The American Journal of Bioethics : AJOB|March 24, 2004
Will lower drug prices jeopardize drug research? A policy fact sheetDonald W Light, Joel Lexchin
BMJ (Clinical Research Ed.)|September 25, 2015
The FDA's new clothesDonald W Light, Joel Lexchin
The New England Journal of Medicine|July 19, 2013
Regulation of drugs for early Alzheimer's diseaseDonald W Light, Jonathan Darrow
Social Science & Medicine (1982)|March 25, 2011
Reflections on commissioning and the English coalition government NHS reformsDonald W Light, Martin Connor
BMJ (Clinical Research Ed.)|April 25, 2015
Why do cancer drugs get such an easy ride?Donald W Light, Joel Lexchin
The Hastings Center Report|August 11, 2006
A conservative case for universal access to health carePaul Menzel, Donald W Light
BMJ (Clinical Research Ed.)|March 18, 2018
Trump blames free riding foreign states for high US drug pricesDonald W Light, Arthur L Caplan
Social Science & Medicine (1982)|September 26, 2020
Pharmaceuticals as a market for "lemons": Theory and practiceDonald W Light, Joel R Lexchin
BMJ (Clinical Research Ed.)|August 9, 2012
Pharmaceutical research and development: what do we get for all that money?Donald W Light, Joel R Lexchin
Journal of Health Economics|August 10, 2005
Extraordinary claims require extraordinary evidenceDonald W Light, Rebecca N Warburton
Pageof 6